1. Multiple myeloma and kidney disease
- Author
-
Natalia Zarankiewicz, Katarzyna Kosz, Martyna Zielińska, Klaudia Remjasz, Aleksandra Kuchnicka, Julia Kuchnicka, Klaudia Sapuła, Jakub Aleksandrowicz, and Wojciech Siedlecki
- Subjects
multiple myeloma ,myeloma cast nephropathy ,bortezomib ,RANKL ,Education ,Sports ,GV557-1198.995 ,Medicine - Abstract
Abstract Background: Multiple myeloma is a clonal plasma cell neoplasm which affects 1% of all malignancies. In this article we reviewed epidemiology, symptoms with particular attention to renal failure and its manifestation in multiple myeloma (MM). Material and methods: This paper was based on medical articles collected in PubMed from 2001 to 2022, medical websites and books. The research has been done by looking through key words such as: „multiple myeloma”, „myeloma cast nephropathy”, „bortezomib”, „RANKL” Results: Multiple myeloma has indolent course and many patients present renal disorders at the moment of diagnosis. The use of novel therapies can reverse renal failure. Conclusions: Treatment of the patients with MM and kidney disease is challenging for health care professionals. Doctors have to adjust treatment to provide the best therapeutic effects.
- Published
- 2022
- Full Text
- View/download PDF